Ravgen

Columbia, United States Founded: 2000 • Age: 26 yrs
Fetal DNA in maternal blood is analyzed for prenatal diagnostics.
Request Access

About Ravgen

Ravgen is a company based in Columbia (United States) founded in 2000.. Ravgen offers products and services including Prenatal Down Syndrome Test, Single Gene Disorder Test, and Non-Invasive Prenatal Paternity Test. Ravgen operates in a competitive market with competitors including Natera, GreenLight Biosciences, Color, BillionToOne and Veritas Genetics, among others.

  • Headquarter Columbia, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ravgen, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $2.48 M (USD), Debt – Conventional

    Oct 27, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Ravgen

Ravgen offers a comprehensive portfolio of products and services, including Prenatal Down Syndrome Test, Single Gene Disorder Test, and Non-Invasive Prenatal Paternity Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Detects extra chromosome 21 in fetal DNA from maternal blood.

Identifies disorders like CF and SMA using non-invasive methods.

Determines paternity with fetal DNA from maternal blood sample.

People of Ravgen
Headcount 1-10
Employee Profiles 1
Board Members and Advisors 12
Employee Profiles
People
Ravinder Dhallan
Chairman & CEO

Unlock access to complete

Board Members and Advisors
people
Mark D. Adams
Advisor
people
Russell Lewis
Advisor
people
Edward K. Mottern
Director
people
Daniel I. Weber
Advisor

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Ravgen

  • Total Funding
  • Total Rounds 1
  • Last Round Debt – Conventional — $2.5M
  • First Round

    (27 Oct 2021)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2021 Amount Debt – Conventional - Ravgen Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Ravgen

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ravgen

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ravgen Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ravgen

Ravgen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, GreenLight Biosciences, Color, BillionToOne and Veritas Genetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of cell-free DNA testing for oncology, women’s health, and organ health
domain founded_year HQ Location
RNA-based platform for life sciences is developed by GreenLight Biosciences.
domain founded_year HQ Location
Cancer care is delivered through a virtual clinic by Color.
domain founded_year HQ Location
Provider of cell-free cancer liquid biopsy test
domain founded_year HQ Location
Genetic testing products for health risks and traits are offered.
domain founded_year HQ Location
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ravgen

Frequently Asked Questions about Ravgen

When was Ravgen founded?

Ravgen was founded in 2000 and raised its 1st funding round 21 years after it was founded.

Where is Ravgen located?

Ravgen is headquartered in Columbia, United States.

What does Ravgen do?

Ravgen was founded in 2000 and is headquartered in Columbia, United States. Operations focus on the biotechnology sector, where non-invasive prenatal diagnostic tests are developed through analysis of fetal DNA in maternal blood. Services include detection of single gene disorders such as cystic fibrosis, sickle cell anemia, and Down syndrome, as well as paternity establishment during the first trimester.

Who are the top competitors of Ravgen?

Ravgen's top competitors include GreenLight Biosciences, Natera and BillionToOne.

What products or services does Ravgen offer?

Ravgen offers Prenatal Down Syndrome Test, Single Gene Disorder Test, and Non-Invasive Prenatal Paternity Test.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available